Advertising
Showing 1 to 15 of 313 entries

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Nov 26/20, Up 55.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CVS is progressing well. We now recommend trailing up the stop (from $82) to $95. If triggered, this would all but guarantee a net investment gain of 30%, when combined with our previous recommendation to cover half.
specialty stores
PAST TOP PICK
(A Top Pick Jan 19/21, Up 42%) Debt is manageable. Free cashflow of about 13B. Well capitalized. Insurance, pharmacy with HealthHub, pharmacy benefit manager. Not expensive at 13x earnings.
specialty stores
BUY
Has done well, raising estimates for 2022. Redefined itself, and the market's realizing it's more than just a drugstore. Centred around health wellness. Trades at 12x earnings. Good cashflow, decent dividend.
specialty stores
HOLD
The PE is still attractive. CVS is adding more health services in their drug stores. Covid vaccinations encourage consumers to buy more items in their stores when they visit. Still a hold and you'll get a decent return. Still some upside here.
specialty stores

Unlock the Weekly Buzzing Stocks

Become a member Or, Sign In
TOP PICK
Recently selected as a top pick by both our research editor Michael O'Reilly and Chris Bulmas. Very successful during the pandemic. Social media mentions increased 538% these last 24h.
specialty stores

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Nov 26/20, Up 37.69%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CVS is progressing well. We recommend trailing up the stop (from $70) to $82. If triggered this would result in a net investment gain over 21%, when combined by our previous recommendation to cover half.
specialty stores
COMMENT
They report Wednesday. They've been a roll because of the Covid vaccine and superior execution compared to Walgreens. But can they continue their streak as the pandemic winds down? They do have a huge health insurance business.
specialty stores
PAST TOP PICK
(A Top Pick Feb 26/20, Up 39%) He still likes it. It has a unique business model: a pharmacy, pharmacy benefit management (PBM) and health insurer. Pays a good dividend, diversified and trades around 10x earnings. Free-cash flow yield is almost 9%. It's a durable business.
specialty stores
BUY
It's cheap, and trades well below the market multiple. Booster shots will be a big benefit to CVS.
specialty stores
BUY
Vertically integrated, growing dynamically. CVS has health insurance with Aetna, pharmacy benefit manager with CareMark, and HealthHub offering in-store diagnostics. Better choice than WBA.
specialty stores
PAST TOP PICK
(A Top Pick Aug 21/20, Up 34%) Absolutely he'll stick with it. Trades at a fine PE. It's not just pharmacies but health insurance to add up to a vertical health business.
specialty stores
HOLD
WBA has operations in the US and UK. Stays in drug retail and expands geographically. Doesn't grow quickly, but it's not an income stock either. Growth profile not attractive. She owns CVS instead, with its vertically integrated strategy.
specialty stores
PAST TOP PICK

(A Top Pick Jun 29/20, Up 32%) They became big after buying Aetna. They're broadening offering within stores to offer services like nurse practitioners. They think beyond just being a drug store. They're well-positioned in their industry. Take a long-term view, but you can buy this at current prices.

specialty stores
BUY

He prefers CVS to WBA. WBA has spun its wheels a bit. CVS has better management, and it's vertically integrated with Aetna and its pharmacy benefit manager. As the pandemic eases, its revenues from Covid will shift to other areas, such as HealthHUB for chronic conditions.

specialty stores
BUY
He still likes it and has for a long time. Sure, there will be frustrating periods owning this. He was patient with this, and now CVS shares are starting to climb, because the market views it as a healthcare provider, including insurance, and not just a drug store. They have 12,000 stores. Their Health Hub is set up to be an intermediate step for people to go before (or instead of) the emergency ward (i.e. high blood pressure), and HH's future looks bright.
specialty stores
Showing 1 to 15 of 313 entries

CVS Health Corp(CVS-N) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 14

Neutral - Hold Signals / Votes : 3

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 17

Stockchase rating for CVS Health Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CVS Health Corp(CVS-N) Frequently Asked Questions

What is CVS Health Corp stock symbol?

CVS Health Corp is a American stock, trading under the symbol CVS-N on the New York Stock Exchange (CVS). It is usually referred to as NYSE:CVS or CVS-N

Is CVS Health Corp a buy or a sell?

In the last year, 17 stock analysts published opinions about CVS-N. 14 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for CVS Health Corp.

Is CVS Health Corp a good investment or a top pick?

CVS Health Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for CVS Health Corp.

Why is CVS Health Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CVS Health Corp worth watching?

17 stock analysts on Stockchase covered CVS Health Corp In the last year. It is a trending stock that is worth watching.

What is CVS Health Corp stock price?

On 2022-01-18, CVS Health Corp (CVS-N) stock closed at a price of $104.51.